Oral valproic acid vs placeboChange in pulmonary function · ambulatory adults with SMA type III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted24 participantsLow
Oral valproic acid plus acetyl‐L‐carnitine vs placeboChange in pulmonary function · non‐ambulatory children with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 24 participantsLow